TFEB and cancer: RNA-based therapeutics are expected to soar after the success of RNA-based vaccines; in this sense, numerous studies indicate TFEB is an effective target for the modulation of autophagy and lysosomal activity to successfully counteract different pathological conditions, including cancer [200,201,202,203,204].